H. Ozturk Et Al. , "Tocilizumab for the Treatment of Behcet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy," OCULAR IMMUNOLOGY AND INFLAMMATION , vol.26, no.7, pp.1005-1014, 2018
Ozturk, H. Et Al. 2018. Tocilizumab for the Treatment of Behcet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy. OCULAR IMMUNOLOGY AND INFLAMMATION , vol.26, no.7 , 1005-1014.
Ozturk, H., ORAY, M., & Tugal-Tutkun, I., (2018). Tocilizumab for the Treatment of Behcet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy. OCULAR IMMUNOLOGY AND INFLAMMATION , vol.26, no.7, 1005-1014.
Ozturk, Hilal, Merih ORAY, And Ilknur Tugal-Tutkun. "Tocilizumab for the Treatment of Behcet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy," OCULAR IMMUNOLOGY AND INFLAMMATION , vol.26, no.7, 1005-1014, 2018
Ozturk, Hilal E. Et Al. "Tocilizumab for the Treatment of Behcet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy." OCULAR IMMUNOLOGY AND INFLAMMATION , vol.26, no.7, pp.1005-1014, 2018
Ozturk, H. ORAY, M. And Tugal-Tutkun, I. (2018) . "Tocilizumab for the Treatment of Behcet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy." OCULAR IMMUNOLOGY AND INFLAMMATION , vol.26, no.7, pp.1005-1014.
@article{article, author={Hilal Eser Öztürk Et Al. }, title={Tocilizumab for the Treatment of Behcet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy}, journal={OCULAR IMMUNOLOGY AND INFLAMMATION}, year=2018, pages={1005-1014} }